The world's first ｜ K medicine single medicine or combined chemotherapy first -line therapy for recurrence and metastasis of head and neck squamous carcinoma 5 years OS data
*For medical professionals for reading referenceKeynote studies the five -year OS ...
K-medicine, a "long survival" PD-1 inhibitor
*For medical professionals for reading referenceESMO announced the long -term OS f...